본문 바로가기
KERD
논문KCI 등재

악성 담관 폐쇄에서 내시경적 스텐트 삽입술

Endoscopic Biliary Stenting in Patients with Malignant Biliary Obstruction

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류내과학

초록

담도암은 예후가 아주 불량하며 환자의 대부분이 진단 당시에 수술이 불가능한 경우가 많다. 이러한 환자에서 담도 배액을 통한 대증적인 치료법이 제공되어야 한다. 담도 배액을 통한 대증 치료의 목적은 생존기간이나 항암치료 동안 담도염이나 담즙성 복막염을 예방하고 가능한 많은 간기능을 보존하는 것이다. 내시경 혹은 경피경간을 통한 담도 배액이 수술이 불가능한 환자에서 더욱 중요한 역할을 하고 있다. 경피경간담도배액술에 비해 내시경을 이용한 담도 배액은 덜 침습적이며 환자가 더욱 편리하며 입원기간의 단축과 같은 장점이 있다. 따라서 내시경을 이용한 담도 배액은 수술이 불가능한 담도암 환자에서 황달의 경감을 위해 최선의 치료법으로 고려되어야 한다.

Abstract

Cholangiocarcinoma has an extremely poor prognosis and the majority of patients have an incurable disease at the time of presentation. These patients should be offered palliative drainage management. The aims of palliation are to prevent cholangitis or bile peritonitis in the course of follow-up or chemotherapy, and to preserve the functional volume of the liver as much as possible. Endoscopic or percutaneous drainage has become increasingly important in the palliative care of patients with unresectable cholangiocarcinoma. Compared to the percutaneous approach, endoscopic biliary stenting is less invasive, more comfortable, and results in a reduced hospital stay. Therefore, endoscopic biliary stenting should be considered the first-line therapy for jaundice palliation in unresectable cholangiocarcinoma.

참고문헌 (36)

  1. Hedin M, "The origin of the word stent", Acta Radiol, 38, pp.937~939 (1997)
  2. Jemal A, "Cancer statistics, 2003", CA Cancer J Clin, 53, pp.5~26 (2003)
  3. Abraham NS, "Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life", Gastrointest Endosc, 56, pp.835~841 (2002)
  4. Flamm CR, "Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies", Gastrointest Endosc, 56, pp.218S~225S (2002)
  5. Soehendra N, "Palliative bile duct drainage - a new endoscopic method of introducing a transpapillary drain", Endoscopy, 12, pp.8~11 (1980)
  6. Tringali A, "A prospective, randomized multicenter trial comparing doubleLayer and polyethylene stents for malignant distal common bile duct strictures", Endoscopy, 35, pp.992~997 (2003)
  7. Ghosh S, "Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid", Gut, 35, pp.1757~1759 (1994)
  8. Barrioz T, "Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxaci", Lancet, 344, pp.581~582 (1994)
  9. Luman W, "A combination of ciprofloxacin and Rowachol does not prevent biliary stent occlusion", Gastrointest Endosc, 49, pp.316~321 (1999)
  10. van Berkel AM, "A prospective randomized trial of teflon versus polyethylene stents for distal malignant biliary obstruction", Endoscopy, 30, pp.681~686 (1998)
  11. Terruzzi V, "Prospective randomized trial comparing tannenbaum teflon and standard polyethylene stents in distal malignant biliary stenosis", Gastrointest Endosc, 51, pp.23~27 (2000)
  12. England RE, "A prospective randomised multicentre trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures", Gut, 46, pp.395~400 (2000)
  13. Catalano MF, ""Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture", Gastrointest Endosc, 55, pp.354~358 (2002)
  14. Landoni N, "Randomized prospective study to compare the efficiency between standard plastic and polyurethane stents in biliary tract malignant obstruction", Acta Gastroenterol Latinoam, 30, pp.501~504 (2000)
  15. Schilling D, "Prospective, randomized, single-center trial comparing 3 different 10F plastic stents in malignant mid and distal bile duct strictures", Gastrointest Endosc, 58, pp.54~58 (2003)
  16. van Berkel AM, "A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction", Endoscopy, 35, pp.478~482 (2003)
  17. Costamagna G, "Hydrophilic hydromer-coated polyurethane stents versus uncoated stents in malignant biliary obstruction: a randomized trial", Gastrointest Endosc, 51, pp.8~11 (2000)
  18. Sung JJ, "Omitting side-holes in biliary stents does not improve drainage of the obstructed biliary system: a prospective randomized trial", Gastrointest Endosc, 40, pp.321~325 (1994)
  19. Seitz U, "Prolonged patency with a new-design teflon biliary prosthesis", Endoscopy, 26, pp.478~482 (1994)
  20. Binmoeller KF, "The Tannenbaum stent: a new plastic biliary stent without side holes", Am J Gastroenterol, 90, pp.1764~1768 (1995)
  21. van Berkel AM, "A prospective randomized trial of tannenbaum- type teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction", Eur J Gastroenterol Hepatol, 16, pp.213~217 (2004)
  22. Speer AG, "Endoscopic management of malignant biliary obstruction: stents of 10 french gauge are preferable to stents of 8 french gauge", Gastrointest Endosc, (34), pp.412~417 (1988)
  23. Kadakia SC, "Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases", Gastrointest Endosc, 38, pp.454~459 (1992)
  24. Suk KT, "Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction", Gastrointest Endosc, 64, pp.522~529 (2006)
  25. Guthrie CM, "Changing trends in the management of extrahepatic cholangiocarcinoma", Br J Surg, 80, pp.1434~1439 (1993)
  26. Mueller PR, "Obstruction of the left hepatic duct: diagnosis and treatment by selective fine-needle cholangiography and percutaneous biliary drainage", Radiology, 145, pp.297~302 (1982)
  27. Polydorou AA, "A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction", Endoscopy, 21, pp.266~271 (1989)
  28. Motte S, "Risk factors for septicemia following endoscopic biliary stenting", Gastroenterology, 101, pp.1374~1381 (1991)
  29. Rerknimitr R, "Result of endoscopic biliary drainage in hilar cholangiocarcinoma", J Clin Gastroenterol, 38, pp.518~523 (2004)
  30. Cheng JL, "Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents", Gastrointest Endosc, 5, pp.33~39 (2002)
  31. Dumas R, "Endoscopic bilateral metal stent placement for malignant hilar stenoses: identi fication of optimal technique", Gastrointest Endosc, 51, pp.334~338 (2000)
  32. Silverman W, "New technique for bilateral metal mesh stent insertion to treat hilar cholangiocarcinoma", Gastrointest Endosc, 43, pp.61~63 (1996)
  33. Lee JH, "Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma: a pilot study of a newly designed Y stent", Gastrointest Endosc, 66, pp.364~369 (2007)
  34. Park DH, "Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stent in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos)", Gastrointest Endosc, 69, pp.1357~1360 (2009)
  35. Kim JY, "Usefulness of slimmer and open-cell design stent for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video", Gastrointest Endosc (2009)
  36. Lee DK, "The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane", Gastrointest Endosc, 61, pp.296~301 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (4건)